| Elizabeth Arden, Inc. | Key Financials | Relative to Peer Avg |
|---|---|---|
| Quarterly Revenue Growth | 10.59% | |
| Annual Revenue Growth | 23.35% | |
| Quarterly Net Income Growth | -158.10% | |
| Annual Net Income Growth | 262.01% | |
| Quarterly Free Cash Flow Growth | ||
| Total Debt Relative to Total Capital | 47.23% | |
| Operating Margin | 2.47% | |
| Return on Equity | 9.392% |
| Elizabeth Arden, Inc. (RDEN) Dilution Analysis | |||
|---|---|---|---|
| Latest EPS | -$0.04 | N/A | |
| Company | Revenue* | Net Income* | Rating | Sentiment |
|---|---|---|---|---|
| PG | 20,598.00 | 2,566.00 | Sign up to view | |
| KMB | 5,318.00 | 531.00 | Sign up to view | |
| CL | 4,315.00 | 460.00 | Sign up to view | |
| AVP | 2,483.70 | -13.70 | Sign up to view | |
| EL | 2,291.80 | 178.80 | Sign up to view | |
| CLX | 1,413.00 | 133.00 | Sign up to view | |
| MJN | 1,037.90 | 172.10 | Sign up to view | |
| CHD | 779.30 | 107.70 | Sign up to view | |
| NUS | 548.29 | 54.28 | Sign up to view | |
| REV | 331.90 | -6.90 | Sign up to view | |